330 related articles for article (PubMed ID: 17111148)
1. Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height.
Puusaari I; Damato B; Kivelä T
Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):522-33. PubMed ID: 17111148
[TBL] [Abstract][Full Text] [Related]
2. Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness: a matched case-control study.
Kivelä T; Puusaari I; Damato B
Ophthalmology; 2003 Nov; 110(11):2235-44. PubMed ID: 14597535
[TBL] [Abstract][Full Text] [Related]
3. Ocular complications after iodine brachytherapy for large uveal melanomas.
Puusaari I; Heikkonen J; Kivelä T
Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
[TBL] [Abstract][Full Text] [Related]
4. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
5. Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma.
Caminal JM; Padrón-Pérez N; Arias L; Masuet-Aumatell C; Gutiérrez C; Piulats JM; Pera J; Català J; Rubio MJ; Arruga J
Eye (Lond); 2016 Jun; 30(6):833-42. PubMed ID: 27034202
[TBL] [Abstract][Full Text] [Related]
6. Iodine 125 plaque brachytherapy versus transscleral tumor resection in the treatment of large uveal melanomas.
Bechrakis NE; Bornfeld N; Zöller I; Foerster MH
Ophthalmology; 2002 Oct; 109(10):1855-61. PubMed ID: 12359606
[TBL] [Abstract][Full Text] [Related]
7. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
Puusaari I; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
9. [Iodine-125 brachytherapy and trans-scleral tumor resection in large uveal melanomas].
Bechrakis NE; Bornfeld N; Zöller I; Foerster MH
Ophthalmologe; 2001 Aug; 98(8):736-42. PubMed ID: 11552413
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant proton beam irradiation followed by transscleral resection of uveal melanoma in 106 cases.
Willerding GD; Cordini D; Moser L; Krause L; Foerster MH; Bechrakis NE
Br J Ophthalmol; 2016 Apr; 100(4):463-7. PubMed ID: 26224096
[TBL] [Abstract][Full Text] [Related]
11. Incidence and indications for pars plana vitrectomy following the treatment of posterior uveal melanomas in Scotland.
Chia SN; Smith HB; Hammer HM; Kemp EG
Eye (Lond); 2015 Jun; 29(6):748-56. PubMed ID: 25853443
[TBL] [Abstract][Full Text] [Related]
12. 125I plaque brachytherapy for anterior uveal melanomas.
Lumbroso-Le Rouic L; Charif Chefchaouni M; Levy C; Plancher C; Dendale R; Asselain B; Solignac S; Mazal A; Desjardins L
Eye (Lond); 2004 Sep; 18(9):911-6. PubMed ID: 15002010
[TBL] [Abstract][Full Text] [Related]
13. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma.
Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A
Br J Ophthalmol; 1996 Aug; 80(8):732-9. PubMed ID: 8949719
[TBL] [Abstract][Full Text] [Related]
14. Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma.
King B; Morales-Tirado VM; Wynn HG; Gao BT; Ballo MT; Wilson MW
Am J Ophthalmol; 2017 Apr; 176():40-45. PubMed ID: 28048976
[TBL] [Abstract][Full Text] [Related]
15. Ten-year results of transscleral resection of large uveal melanomas: local tumour control and metastatic rate.
Bechrakis NE; Petousis V; Willerding G; Krause L; Wachtlin J; Stroux A; Foerster MH
Br J Ophthalmol; 2010 Apr; 94(4):460-6. PubMed ID: 19965818
[TBL] [Abstract][Full Text] [Related]
16. 23-mm iodine-125 plaque for uveal melanoma: benefit of vitrectomy and silicone oil on visual acuity.
McCannel TA; Kamrava M; Demanes J; Lamb J; Bartlett JD; Almanzor R; Chun M; McCannel CA
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2461-2467. PubMed ID: 27638702
[TBL] [Abstract][Full Text] [Related]
17. Endoresection of large uveal melanomas: clinical results in a consecutive series of 200 cases.
Biewald E; Lautner H; Gök M; Horstmann GA; Sauerwein W; Flühs D; Bornfeld N
Br J Ophthalmol; 2017 Feb; 101(2):204-208. PubMed ID: 27121095
[TBL] [Abstract][Full Text] [Related]
18. Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool.
Aziz HA; Singh N; Bena J; Wilkinson A; Singh AD
JAMA Ophthalmol; 2016 Jun; 134(6):615-20. PubMed ID: 27101414
[TBL] [Abstract][Full Text] [Related]
19. Ruthenium-106 plaque brachytherapy for uveal melanoma.
Tarmann L; Wackernagel W; Avian A; Mayer C; Schneider M; Winkler P; Langmann G
Br J Ophthalmol; 2015 Dec; 99(12):1644-9. PubMed ID: 25979763
[TBL] [Abstract][Full Text] [Related]
20. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
